Working vigorously to reduce cardiovascular deaths, U.S. health officials have announced a national program that partners with private insurance companies to prevent one million heart attacks and strokes over five years.

In a what came as a surprise move to many, the U.S. Food and Drug Administration advisory committee today voted to recommend heart arrhythmia drug rivaroxiban (Xarelto) for approval.

American adults have gotten heavier and a sizeable percentage don't live a healthy lifestyle. Young adults and teens seem to be following in those same footsteps.

Patients who receive brain stents after a stroke have a much higher chance of suffering another stroke or dying. Receiving aggressive medical therapy was found to be more than twice as effective.

U.S. Food and Drug Administration reviewers have warned against immediate approval of rivaroxaban (Xarelto) and questioned effectiveness of the medication for preventing stroke in high-risk atrial fibrillation patients.

Women who don't receive adequate food and nutrition as they are growing up, particularly during the adolescent years, may be more likely to develop coronary artery disease later in life.

When calcium builds up in blood vessels it increases the risk of heart disease, including the risk of heart attack. It may also be linked to brain changes that increase the risk of stroke and dementia.

It's the news that people with a sweet tooth have been waiting to hear! Eating large amounts of chocolate may cut the risk of developing heart disease by a third.

Stroke patients admitted on weekends have a higher chance of dying. But that's not the case for those that seek treatment at a hospital with a state-certified stroke center.

Atrial fibrillation, a common heart arrhythmia, is generally treated with a standard drug warfarin. However, a study suggests a new drug might provide the same treatment, but with a lower risk of stroke and embolism.